A Monolayer System for the Efficient Generation of Motor Neuron Progenitors and Functional Motor Neurons from Human Pluripotent Stem Cells.

cellular models hiPSC induced pluripotent stem cells motor neuron progenitors spinal motor neurons spinal muscular atrophy

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
07 05 2021
Historique:
received: 31 03 2021
revised: 27 04 2021
accepted: 04 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 9 11 2021
Statut: epublish

Résumé

Methods for the conversion of human induced pluripotent stem cells (hiPSCs) into motor neurons (MNs) have opened to the generation of patient-derived in vitro systems that can be exploited for MN disease modelling. However, the lack of simplified and consistent protocols and the fact that hiPSC-derived MNs are often functionally immature yet limit the opportunity to fully take advantage of this technology, especially in research aimed at revealing the disease phenotypes that are manifested in functionally mature cells. In this study, we present a robust, optimized monolayer procedure to rapidly convert hiPSCs into enriched populations of motor neuron progenitor cells (MNPCs) that can be further amplified to produce a large number of cells to cover many experimental needs. These MNPCs can be efficiently differentiated towards mature MNs exhibiting functional electrical and pharmacological neuronal properties. Finally, we report that MN cultures can be long-term maintained, thus offering the opportunity to study degenerative phenomena associated with pathologies involving MNs and their functional, networked activity. These results indicate that our optimized procedure enables the efficient and robust generation of large quantities of MNPCs and functional MNs, providing a valid tool for MNs disease modelling and for drug discovery applications.

Identifiants

pubmed: 34066970
pii: cells10051127
doi: 10.3390/cells10051127
pmc: PMC8151197
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondazione Cariplo
ID : 2019-3396
Organisme : AFM-Téléthon
ID : 16177
Organisme : AFM-Téléthon
ID : 18221
Organisme : AFM-Téléthon
ID : 21565
Organisme : Fondazione Cassa Rurale Trento Rovereto
ID : 2018.256

Références

Development. 2014 Feb;141(3):491-501
pubmed: 24449832
Stem Cells Transl Med. 2019 Dec;8(12):1272-1285
pubmed: 31631575
Nat Protoc. 2009;4(9):1295-304
pubmed: 19696748
Cell Stem Cell. 2011 Sep 2;9(3):205-18
pubmed: 21852222
Nat Biotechnol. 2001 Dec;19(12):1129-33
pubmed: 11731781
Mol Biol Rep. 2014 Mar;41(3):1713-21
pubmed: 24469709
Stem Cell Res. 2018 Oct;32:126-134
pubmed: 30278374
Elife. 2020 Jun 23;9:
pubmed: 32571478
Nat Rev Genet. 2000 Oct;1(1):20-9
pubmed: 11262869
J Cell Sci. 2018 Feb 12;131(3):
pubmed: 29361526
Biophys Chem. 2017 Oct;229:68-76
pubmed: 28511915
Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
Expert Opin Drug Discov. 2015 Jun;10(6):615-29
pubmed: 25891144
Dev Biol. 2008 Jan 1;313(1):398-407
pubmed: 18062957
Oncotarget. 2017 Jun 27;8(26):42030-42042
pubmed: 28159932
Toxicol Sci. 2011 Dec;124(2):370-7
pubmed: 21934132
PLoS One. 2009 Aug 24;4(8):e6722
pubmed: 19701462
Nat Commun. 2014 Mar 13;5:3449
pubmed: 24622388
Dev Growth Differ. 2016 May;58(4):400-8
pubmed: 27189526
Stem Cells Int. 2018 Jan 24;2018:3628578
pubmed: 29531534
Front Cell Neurosci. 2014 Oct 09;8:293
pubmed: 25346659
Nat Commun. 2015 Mar 25;6:6626
pubmed: 25806427
Cells. 2020 Aug 12;9(8):
pubmed: 32806773
Neuronal Signal. 2019 Sep;3(3):NS20190019
pubmed: 32269838
Cells Tissues Organs. 2013;198(2):127-38
pubmed: 24158103
Front Neurosci. 2016 Mar 30;10:121
pubmed: 27065786
Br J Cancer. 2005 Feb 28;92(4):751-9
pubmed: 15685243
Sci Rep. 2017 Nov 16;7(1):15752
pubmed: 29146941
Mol Neurobiol. 2016 Apr;53(3):1589-1600
pubmed: 25663198
Nat Neurosci. 2001 Nov;4 Suppl:1183-91
pubmed: 11687828
Mol Ther Methods Clin Dev. 2017 Jan 10;4:115-125
pubmed: 28344997
Nat Neurosci. 2016 Apr;19(4):542-53
pubmed: 27021939
Stem Cell Res Ther. 2014 Jul 14;5(4):87
pubmed: 25157556
J Neurosci. 2013 Jan 9;33(2):574-86
pubmed: 23303937
Nat Rev Neurosci. 2010 Mar;11(3):176-87
pubmed: 20107441
Aging Dis. 2013 Oct 01;4(5):295-310
pubmed: 24124634
Development. 2008 Nov;135(22):3687-96
pubmed: 18927156
Cells. 2019 Dec 30;9(1):
pubmed: 31905823
J Mol Neurosci. 2021 Mar;71(3):662-674
pubmed: 32856205
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8299-304
pubmed: 21525408

Auteurs

Alessandro Cutarelli (A)

Laboratory of Stem Cell Biology, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, 38123 Trento, Italy.

Vladimir A Martínez-Rojas (VA)

Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) & LabSSAH, Bruno Kessler Foundation (FBK), 38123 Trento, Italy.

Alice Tata (A)

Laboratory of Stem Cell Biology, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, 38123 Trento, Italy.

Ingrid Battistella (I)

Laboratory of Stem Cell Biology, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, 38123 Trento, Italy.

Daniela Rossi (D)

Laboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Daniele Arosio (D)

Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) & LabSSAH, Bruno Kessler Foundation (FBK), 38123 Trento, Italy.

Carlo Musio (C)

Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) & LabSSAH, Bruno Kessler Foundation (FBK), 38123 Trento, Italy.

Luciano Conti (L)

Laboratory of Stem Cell Biology, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, 38123 Trento, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH